Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease

This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.

Detalles Bibliográficos
Autores principales: Hoertel, Nicolas, Boulware, David R., Sánchez-Rico, Marina, Burgun, Anita, Limosin, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667321/
https://www.ncbi.nlm.nih.gov/pubmed/36378313
http://dx.doi.org/10.1001/jamanetworkopen.2022.42140
Descripción
Sumario:This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.

Ejemplares similares